Loading...
XIST
ECILC
Market cap1.22bUSD
Nov 12, Last price  
83.50TRY
Name

EIS Eczacibasi Ilac Sinai ve Finansal Yatirimlar Sanayi ve Ticaret AS

Chart & Performance

D1W1MN
XIST:ECILC chart
P/E
27.39
P/S
5.80
EPS
3.05
Div Yield, %
1.41%
Shrs. gr., 5y
Rev. gr., 5y
61.12%
Revenues
9.87b
+12.59%
996,315,328921,799,615805,314,601874,700,000913,212,000973,552,0001,087,267,0001,126,009,0001,046,781,0001,170,563,0001,412,645,000597,909,000692,094,000877,076,000909,132,0001,103,515,0001,830,613,0006,479,496,0008,767,346,0009,871,046,000
Net income
2.09b
+104.06%
43,237,587454,331,22072,409,375290,249,00060,380,00088,510,00032,689,00061,414,000-43,293,00067,647,000184,803,000146,095,000240,119,000162,728,000322,089,000755,060,0004,177,760,0002,739,838,0001,023,611,0002,088,766,000
CFO
2.21b
+6.04%
96,031,869-151,760,677-67,184,80444,696,0002,394,00020,348,000-47,737,000-38,148,00013,715,00038,651,00054,462,00093,611,000175,271,000171,325,00077,043,000517,111,000113,449,0001,770,562,0002,085,517,0002,211,475,000
Dividend
May 14, 20251.75116 TRY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a Turkish enterprise, operating predominantly in the health and real estate development sectors through its various subsidiaries. Its Health division is responsible for the production and distribution of pharmaceutical goods for both human and veterinary applications. Concurrently, the Real Estate Development segment is engaged in property creation and offers consultancy pertaining to land development and project oversight. This company, established in Istanbul, Turkey, in 1951, functions as a subsidiary of Eczacibasi Holding A.S.
IPO date
Jun 25, 1990
Employees
Domiciled in
TR
Incorporated in
TR

Valuation

Title
TRY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT